{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:13:33Z","timestamp":1793880813909,"version":"4.7.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41571-026-01165-8","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T09:45:10Z","timestamp":1781862310000},"page":"694-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cancer burden and control in China: landscape, trends and challenges"],"prefix":"10.1038","volume":"23","author":[{"given":"Changfa","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1159-1884","authenticated-orcid":false,"given":"Wanqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"1165_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1165_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl Cancer Cent. 4, 47\u201353 (2024).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1165_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W., Chen, H. D., Yu, Y. W., Li, N. & Chen, W. Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. Med. J. 134, 783\u2013791 (2021).","journal-title":"Chin. Med. J."},{"key":"1165_CR5","first-page":"400","volume":"48","author":"K Sun","year":"2026","unstructured":"Sun, K. et al. Cancer incidence and mortality across diverse geographical regions in China, 2024. Chin. J. Oncol. 48, 400\u2013412 (2026).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR6","doi-asserted-by":"publisher","unstructured":"Zheng, R. et al. Cancer incidence and mortality in China, 2024. J. Natl Cancer Cent. https:\/\/doi.org\/10.1016\/j.jncc.2025.10.003 (2026).","DOI":"10.1016\/j.jncc.2025.10.003"},{"key":"1165_CR7","first-page":"48","volume":"26","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. Annual report on status of cancer in China, 2010. Chin. J. Cancer Res. 26, 48\u201358 (2014).","journal-title":"Chin. J. Cancer Res."},{"key":"1165_CR8","unstructured":"National Bureau of Statistics of China. China\u2019s National Economic and Population Statistics in 2025 https:\/\/www.stats.gov.cn\/english\/PressRelease\/202601\/t20260119_1962328.html (2026)."},{"key":"1165_CR9","unstructured":"Ferlay, J. et al. Global Cancer Observatory: Cancer Tomorrow (version 1.1) https:\/\/gco.iarc.who.int\/tomorrow (2024)."},{"key":"1165_CR10","unstructured":"State Council of China. The Healthy China 2030 Blueprint https:\/\/www.gov.cn\/zhengce\/2016-10\/25\/content_5124174.htm (2016)."},{"key":"1165_CR11","unstructured":"State Council of China. The Healthy China Initiative (2019-2030) https:\/\/www.nhc.gov.cn\/guihuaxxs\/c100133\/201907\/2a6ed52f1c264203b5351bdbbadd2da8.shtml (2019)."},{"key":"1165_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.vhri.2017.04.001","volume":"12","author":"X Tan","year":"2017","unstructured":"Tan, X., Liu, X. & Shao, H. Healthy China 2030: a vision for health care. Value Health Reg. Issues 12, 112\u2013114 (2017).","journal-title":"Value Health Reg. Issues"},{"key":"1165_CR13","unstructured":"National Health Commission. Implementation Plan for the Cancer Prevention and Control Action (2023\u20132030) https:\/\/www.nhc.gov.cn\/ylyjs\/gzdt\/202311\/9b7882e607324bda8a8222d4fd39f2fd.shtml (2023)."},{"key":"1165_CR14","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","volume":"21","author":"W Wei","year":"2020","unstructured":"Wei, W. et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 21, e342\u2013e349 (2020).","journal-title":"Lancet Oncol."},{"key":"1165_CR15","unstructured":"He, J. et al. Cancer Atlas in China. 74\u201396 (SinoMaps Press, 2019)."},{"key":"1165_CR16","unstructured":"Ferlay, J. Cancer Today (Version 1.1) (Global Cancer Observatory, International Agency for Research on Cancer & World Health Organization, 2024); https:\/\/gco.iarc.who.int\/today."},{"key":"1165_CR17","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S1470-2045(24)00015-9","volume":"25","author":"AB Webb","year":"2024","unstructured":"Webb, A. B. et al. Considerations for using potential surrogate endpoints in cancer screening trials. Lancet Oncol. 25, e183\u2013e192 (2024).","journal-title":"Lancet Oncol."},{"key":"1165_CR18","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1016\/S2468-2667(21)00157-2","volume":"6","author":"H Zeng","year":"2021","unstructured":"Zeng, H. et al. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study. Lancet Public Health 6, e877\u2013e887 (2021).","journal-title":"Lancet Public Health"},{"key":"1165_CR19","first-page":"7","volume":"3","author":"T Shan","year":"2023","unstructured":"Shan, T. et al. Disparities in stage at diagnosis for liver cancer in China. J. Natl Cancer Cent. 3, 7\u201313 (2023).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR20","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jtho.2025.02.013","volume":"20","author":"D Xie","year":"2025","unstructured":"Xie, D. et al. Overdiagnosis of lung cancer due to the introduction of low-dose computed tomography in average-risk populations in the people\u2019s republic of China. J. Thorac. Oncol. 20, 884\u2013896 (2025).","journal-title":"J. Thorac. Oncol."},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-025-02256-1","volume":"10","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. China protocol for early screening, precise diagnosis, and individualized treatment of lung cancer. Signal Transduct. Target. Ther. 10, 175 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ije\/dyp392","volume":"39","author":"D Sarfati","year":"2010","unstructured":"Sarfati, D., Blakely, T. & Pearce, N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int. J. Epidemiol. 39, 598\u2013610 (2010).","journal-title":"Int. J. Epidemiol."},{"key":"1165_CR23","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng, H. et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6, e555\u2013e567 (2018).","journal-title":"Lancet Glob. Health"},{"key":"1165_CR24","first-page":"203","volume":"4","author":"H Zeng","year":"2024","unstructured":"Zeng, H. et al. Cancer survival statistics in China 2019-2021: a multicenter, population-based study. J. Natl Cancer Cent. 4, 203\u2013213 (2024).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR25","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA Cancer J. Clin. 76, e70043 (2026).","journal-title":"CA Cancer J. Clin."},{"key":"1165_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ije\/10.2.127","volume":"10","author":"JY Li","year":"1981","unstructured":"Li, J. Y. et al. Atlas of cancer mortality in the People\u2019s Republic of China. An aid for cancer control and research. Int. J. Epidemiol. 10, 127\u2013133 (1981).","journal-title":"Int. J. Epidemiol."},{"key":"1165_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/ije\/9.4.305","volume":"9","author":"B Armstrong","year":"1980","unstructured":"Armstrong, B. The epidemiology of cancer in the Peoples Republic of China. Int. J. Epidemiol. 9, 305\u2013315 (1980).","journal-title":"Int. J. Epidemiol."},{"key":"1165_CR28","first-page":"4","volume":"18","author":"Z Dong","year":"2009","unstructured":"Dong, Z. et al. A report of cancer high incidence scene in China. China Cancer 18, 4\u20139 (2009).","journal-title":"China Cancer"},{"key":"1165_CR29","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1016\/S2468-2667(23)00186-X","volume":"8","author":"C Xia","year":"2023","unstructured":"Xia, C. et al. Cancer screening in China: a steep road from evidence to implementation. Lancet Public Health 8, e996\u2013e1005 (2023).","journal-title":"Lancet Public Health"},{"key":"1165_CR30","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S2214-109X(19)30001-4","volume":"7","author":"T Matsuda","year":"2019","unstructured":"Matsuda, T. & Inoue, M. Moving towards tailored, region-specific cancer-control measures in China. Lancet Glob. Health 7, e175\u2013e176 (2019).","journal-title":"Lancet Glob. Health"},{"key":"1165_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cac2.12393","volume":"43","author":"R Feng","year":"2023","unstructured":"Feng, R. et al. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun. 43, 75\u201386 (2023).","journal-title":"Cancer Commun."},{"key":"1165_CR32","first-page":"2","volume":"1","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Cancer incidence and mortality in China, 2015. J. Natl Cancer Cent. 1, 2\u201311 (2021).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR33","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer, V. A. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 160, 330\u2013338 (2014).","journal-title":"Ann. Intern. Med."},{"key":"1165_CR34","first-page":"306","volume":"5","author":"Y Xu","year":"2025","unstructured":"Xu, Y., Xia, C., Wang, J., Wu, Y. & Chen, W. Divergent trends in the burden of esophageal, gastric, and liver cancers in China. J. Natl Cancer Cent. 5, 306\u2013312 (2025).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui, F. et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg. Infect. Dis. 23, 765\u2013772 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"1165_CR36","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1053\/j.gastro.2024.07.009","volume":"167","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. The global incident gastrointestinal cancers attributable to suboptimal diets from 1990 to 2018. Gastroenterology 167, 1141\u20131151 (2024).","journal-title":"Gastroenterology"},{"key":"1165_CR37","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.7314\/APJCP.2014.15.22.10021","volume":"15","author":"QK Song","year":"2014","unstructured":"Song, Q. K. et al. Age of diagnosis of breast cancer in China: almost 10 years earlier than in the United States and the European Union. Asian Pac. J. Cancer Prev. 15, 10021\u201310025 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1165_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijc.34671","volume":"154","author":"H Zahed","year":"2024","unstructured":"Zahed, H. et al. Age at diagnosis for lung, colon, breast and prostate cancers: an international comparative study. Int. J. Cancer 154, 28\u201340 (2024).","journal-title":"Int. J. Cancer"},{"key":"1165_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102243","volume":"64","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Landscape of young breast cancer under 35 years in China over the past decades: a multicentre retrospective cohort study (YBCC-Catts study). EClinicalMedicine 64, 102243 (2023).","journal-title":"EClinicalMedicine"},{"key":"1165_CR40","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1158\/1055-9965.EPI-24-0005","volume":"33","author":"BH Ang","year":"2024","unstructured":"Ang, B. H., Teo, S. H. & Ho, W. K. Systematic review and meta-analysis of lifestyle and reproductive factors associated with risk of breast cancer in Asian women. Cancer Epidemiol. Biomarkers Prev. 33, 1273\u20131285 (2024).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1165_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2023.062","volume":"5","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Breast cancer screening coverage - China, 2018-2019. China CDC Wkly. 5, 321\u2013326 (2023).","journal-title":"China CDC Wkly."},{"key":"1165_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.20892\/j.issn.2095-3941.2025.0386","volume":"22","author":"S Ma","year":"2025","unstructured":"Ma, S., Sun, K., Han, B., Zheng, R. & Wei, W. Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals. Cancer Biol. Med. 22, 1017\u20131035 (2025).","journal-title":"Cancer Biol. Med."},{"key":"1165_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei, F., Georges, D., Man, I., Baussano, I. & Clifford, G. M. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet 404, 435\u2013444 (2024).","journal-title":"Lancet"},{"key":"1165_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1473-3099(18)30655-8","volume":"19","author":"T Malag\u00f3n","year":"2019","unstructured":"Malag\u00f3n, T. et al. Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study. Lancet Infect. Dis. 19, 317\u2013326 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"1165_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/00224499.2020.1797617","volume":"58","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Wang, X. & Pan, S. Prevalence and patterns of extramarital sex among Chinese men and women: 2000-2015. J. Sex Res. 58, 41\u201350 (2021).","journal-title":"J. Sex Res."},{"key":"1165_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2025.052","volume":"7","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Cervical cancer screening rates among Chinese women - China, 2023-2024. China CDC Wkly. 7, 321\u2013326 (2025).","journal-title":"China CDC Wkly."},{"key":"1165_CR47","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S1473-3099(16)30450-9","volume":"16","author":"XF Pan","year":"2016","unstructured":"Pan, X. F., Li, R., Pan, A. & Larson, H. Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. Lancet Infect. Dis. 16, 1322\u20131323 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"1165_CR48","doi-asserted-by":"publisher","first-page":"r1985","DOI":"10.1136\/bmj.r1985","volume":"390","author":"F Murphy","year":"2025","unstructured":"Murphy, F. China adds HPV shot as first new immunisation programme vaccine in 17 years. BMJ 390, r1985 (2025).","journal-title":"BMJ"},{"key":"1165_CR49","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S2468-2667(19)30162-8","volume":"4","author":"C Xia","year":"2019","unstructured":"Xia, C. et al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health 4, 462\u2013472 (2019).","journal-title":"Lancet Public Health"},{"key":"1165_CR50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","volume":"12","author":"M Li","year":"2024","unstructured":"Li, M., Dal Maso, L., Pizzato, M. & Vaccarella, S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study. Lancet Diabetes Endocrinol. 12, 824\u2013836 (2024).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1165_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S2213-8587(21)00083-8","volume":"9","author":"M Li","year":"2021","unstructured":"Li, M. et al. Mapping overdiagnosis of thyroid cancer in China. Lancet Diabetes Endocrinol. 9, 330\u2013332 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1165_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s43018-025-00907-4","volume":"5","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management. J Natl Cancer Cent. 5, 474\u2013485 (2025).","journal-title":"J Natl Cancer Cent."},{"key":"1165_CR53","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s11427-024-2810-y","volume":"68","author":"Q Zhu","year":"2025","unstructured":"Zhu, Q. et al. Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022. Sci. China Life Sci. 68, 1478\u20131486 (2025).","journal-title":"Sci. China Life Sci."},{"key":"1165_CR54","unstructured":"Ervik, M. et al. Cancer Over Time (Global Cancer Observatory, International Agency for Research on Cancer & World Health Organization, 2024); https:\/\/gco.iarc.who.int\/overtime."},{"key":"1165_CR55","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4143\/crt.2025.264","volume":"57","author":"EH Park","year":"2025","unstructured":"Park, E. H. et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2022. Cancer Res. Treat. 57, 312\u2013330 (2025).","journal-title":"Cancer Res. Treat."},{"key":"1165_CR56","first-page":"336","volume":"9","author":"National Office for Cancer Prevention and Control.","year":"2000","unstructured":"National Office for Cancer Prevention and Control. National Cancer Control and Prevention Plan (1986\u20132000). China Cancer 9, 336\u2013337 (2000).","journal-title":"China Cancer"},{"key":"1165_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/jjco\/hyp187","volume":"40","author":"P Zhao","year":"2010","unstructured":"Zhao, P., Dai, M., Chen, W. & Li, N. Cancer trends in China. Jpn. J. Clin. Oncol. 40, 281\u2013285 (2010).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1165_CR58","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S2214-109X(18)30488-1","volume":"7","author":"W Chen","year":"2019","unstructured":"Chen, W. et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob. Health 7, 257\u2013269 (2019).","journal-title":"Lancet Glob. Health"},{"key":"1165_CR59","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/tobaccocontrol-2018-054583","volume":"28","author":"C Xia","year":"2019","unstructured":"Xia, C. et al. Provincial-level cancer burden attributable to active and second-hand smoking in China. Tob. Control 28, 669\u2013675 (2019).","journal-title":"Tob. Control"},{"key":"1165_CR60","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","volume":"10","author":"B Secretan","year":"2009","unstructured":"Secretan, B. et al. A review of human carcinogens\u2014part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 10, 1033\u20131034 (2009).","journal-title":"Lancet Oncol."},{"key":"1165_CR61","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1016\/S2468-2667(22)00227-4","volume":"7","author":"KH Chan","year":"2022","unstructured":"Chan, K. H. et al. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study. Lancet Public Health 7, e1014\u2013e1026 (2022).","journal-title":"Lancet Public Health"},{"key":"1165_CR62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.46234\/ccdcw2025.124","volume":"7","author":"X Zeng","year":"2025","unstructured":"Zeng, X., Liu, S., Liu, Y. & Xiao, L. Smoking prevalence in urban and rural areas - China, 2024. China CDC Wkly. 7, 751\u2013759 (2025).","journal-title":"China CDC Wkly."},{"key":"1165_CR63","unstructured":"Chinese Center for Disease Control and Prevention. Main Results and Findings of the 2024 China Adult Tobacco Survey. https:\/\/www.chinacdc.cn\/jksj\/jksj04\/202506\/t20250616_307668.html (2025)."},{"key":"1165_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.46234\/ccdcw2022.020","volume":"4","author":"D Sun","year":"2022","unstructured":"Sun, D., Pang, Y., Lyu, J. & Li, L. Current progress and challenges to tobacco control in China. China CDC Wkly. 4, 101\u2013105 (2022).","journal-title":"China CDC Wkly."},{"key":"1165_CR65","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1016\/S2468-2667(23)00242-6","volume":"8","author":"KH Chan","year":"2023","unstructured":"Chan, K. H., Xiao, D., Zhou, M., Peto, R. & Chen, Z. Tobacco control in China. Lancet Public Health 8, e1006\u2013e1015 (2023).","journal-title":"Lancet Public Health"},{"key":"1165_CR66","doi-asserted-by":"publisher","first-page":"777","DOI":"10.46234\/ccdcw2025.128","volume":"7","author":"M Bi","year":"2025","unstructured":"Bi, M., Xie, L., Xi, Z. & Yang, J. The current situation of subnational legislation on smoking ban in indoor public places, indoor workplaces, and public transport - China, 2024. China CDC Wkly. 7, 777\u2013782 (2025).","journal-title":"China CDC Wkly."},{"key":"1165_CR67","doi-asserted-by":"publisher","first-page":"e956","DOI":"10.1016\/S2468-2667(23)00217-7","volume":"8","author":"IY Millwood","year":"2023","unstructured":"Millwood, I. Y. et al. Alcohol intake and cause-specific mortality: conventional and genetic evidence in a prospective cohort study of 512 000 adults in China. Lancet Public Health 8, e956\u2013e967 (2023).","journal-title":"Lancet Public Health"},{"key":"1165_CR68","first-page":"15","volume":"27","author":"P Wei","year":"2021","unstructured":"Wei, P. et al. Alcohol drinking behavior among adults aged 18 and above in China. Food Nutr. China 27, 15\u201319 (2021).","journal-title":"Food Nutr. China"},{"key":"1165_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103698","volume":"105","author":"A Hu","year":"2022","unstructured":"Hu, A. et al. The transition of alcohol control in China 1990-2019: impacts and recommendations. Int. J. Drug Policy 105, 103698 (2022).","journal-title":"Int. J. Drug Policy"},{"key":"1165_CR70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.46234\/ccdcw2021.012","volume":"3","author":"N Ji","year":"2021","unstructured":"Ji, N., Bai, Y., Xu, J., Liu, M. & Jia, A. Time to take actions to reduce the harmful use of alcohol in China. China CDC Wkly. 3, 74\u201377 (2021).","journal-title":"China CDC Wkly."},{"key":"1165_CR71","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Cancer Prevention and Survival: Summary of Global Evidence on Diet, Weight, Physical Activity & What Increases or Decreases Your Risk of Cancer (World Cancer Research Fund\/American Institute for Cancer Research, 2017)."},{"key":"1165_CR72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/nbu.12345","volume":"43","author":"R Thompson","year":"2018","unstructured":"Thompson, R. et al. Major new review of global evidence on diet, nutrition and physical activity: a blueprint to reduce cancer risk. Nutr. Bull. 43, 269\u2013283 (2018).","journal-title":"Nutr. Bull."},{"key":"1165_CR73","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","volume":"51","author":"A McTiernan","year":"2019","unstructured":"McTiernan, A. et al. Physical activity in cancer prevention and survival: a systematic review. Med. Sci. Sports Exerc. 51, 1252\u20131261 (2019).","journal-title":"Med. Sci. Sports Exerc."},{"key":"1165_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12966-023-01470-w","volume":"20","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Trends in insufficient physical activity among adults in China 2010-18: a population-based study. Int. J. Behav. Nutr. Phys. Act. 20, 87 (2023).","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"1165_CR75","unstructured":"State Council of China. National Fitness Plan (2021\u20132025) https:\/\/www.gov.cn\/zhengce\/zhengceku\/2021-08\/03\/content_5629218.htm (2021)."},{"key":"1165_CR76","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer \u2014 viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1165_CR77","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ijc.32394","volume":"146","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Cancer incidence in relation to body fatness among 0.5 million men and women: findings from the China Kadoorie Biobank. Int. J. Cancer 146, 987\u2013998 (2020).","journal-title":"Int. J. Cancer"},{"key":"1165_CR78","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan, X. F., Wang, L. & Pan, A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 9, 373\u2013392 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1165_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.puhe.2024.09.021","volume":"237","author":"P Ting","year":"2024","unstructured":"Ting, P. et al. Prevalence and inequalities of obesity and associated complications in China: a multicentre nationwide survey. Public Health 237, 97\u2013106 (2024).","journal-title":"Public Health"},{"key":"1165_CR80","unstructured":"National Health Commission. Healthy Weight Management Initiative https:\/\/www.nhc.gov.cn\/guihuaxxs\/c100133\/202504\/b5d296bc536e42aa95baead98e792c67.shtml (2025)."},{"key":"1165_CR81","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.46234\/ccdcw2024.268","volume":"6","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Expert consensus and call on actions for weight management in China: advancing healthy China initiative through strategic actions. China CDC Wkly. 6, 1347\u20131353 (2024).","journal-title":"China CDC Wkly."},{"key":"1165_CR82","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E. & Ioannidis, J. P. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607 (2015).","journal-title":"BMJ"},{"key":"1165_CR83","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00125-017-4229-z","volume":"60","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia 60, 1022\u20131032 (2017).","journal-title":"Diabetologia"},{"key":"1165_CR84","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA 326, 2498\u20132506 (2021).","journal-title":"JAMA"},{"key":"1165_CR85","unstructured":"National Health Commission. Diabetes Prevention and Control Initiative (2024-2030) https:\/\/www.nhc.gov.cn\/ylyjs\/gzdt\/202407\/330feafa9cd7458080c05dcdfd380af8.shtml (2024)."},{"key":"1165_CR86","unstructured":"Chinese Nutrition Society. Dietary Guidelines for Chinese Residents (2022) (People\u2019s Health Publishing House, 2022)."},{"key":"1165_CR87","doi-asserted-by":"publisher","first-page":"401","DOI":"10.46234\/ccdcw2024.078","volume":"6","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Trends in fruit and vegetable intake among the labor force population - China, 2010-2018. China CDC Wkly. 6, 401\u2013407 (2024).","journal-title":"China CDC Wkly."},{"key":"1165_CR88","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/nu14071433","volume":"14","author":"Q Zhu","year":"2022","unstructured":"Zhu, Q. et al. Association between dietary fiber intake and hyperuricemia among Chinese adults: analysis of the China adult chronic disease and nutrition surveillance (2015). Nutrients 14, 1433 (2022).","journal-title":"Nutrients"},{"key":"1165_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/nutrit\/nuz075","volume":"78","author":"D Yu","year":"2020","unstructured":"Yu, D., Zhao, L. & Zhao, W. Status and trends in consumption of grains and dietary fiber among Chinese adults (1982-2015). Nutr. Rev. 78, 43\u201353 (2020).","journal-title":"Nutr. Rev."},{"key":"1165_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205045","volume":"13","author":"F Huang","year":"2018","unstructured":"Huang, F. et al. Dietary calcium intake and food sources among Chinese adults in CNTCS. PLoS ONE 13, e0205045 (2018).","journal-title":"PLoS ONE"},{"key":"1165_CR91","first-page":"5","volume":"27","author":"Y Dongmei","year":"2021","unstructured":"Dongmei, Y. et al. Intake of energy and major nutrients among Chinese residents, 2015-2017. Food Nutr. China 27, 5\u201310 (2021).","journal-title":"Food Nutr. China"},{"key":"1165_CR92","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00125-020-05091-x","volume":"63","author":"H Du","year":"2020","unstructured":"Du, H. et al. Red meat, poultry and fish consumption and risk of diabetes: a 9 year prospective cohort study of the China Kadoorie Biobank. Diabetologia 63, 767\u2013779 (2020).","journal-title":"Diabetologia"},{"key":"1165_CR93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/nu17020334","volume":"17","author":"Z Chang","year":"2025","unstructured":"Chang, Z. et al. Trajectories of nutritional quality, diet-related environmental impact, and diet cost in China: how much does ultra-processed food and drink consumption matter? Nutrients 17, 334 (2025).","journal-title":"Nutrients"},{"key":"1165_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02829-3","volume":"21","author":"P Zhuang","year":"2023","unstructured":"Zhuang, P. et al. Preserved vegetable consumption and its association with mortality among 440,415 people in the China Kadoorie Biobank. BMC Med. 21, 135 (2023).","journal-title":"BMC Med."},{"key":"1165_CR95","unstructured":"World Health Organization. Personal Habits and Indoor Combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100E (IARC Publications, 2012)."},{"key":"1165_CR96","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1002\/ijc.24293","volume":"124","author":"X Guo","year":"2009","unstructured":"Guo, X. et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int. J. Cancer 124, 2942\u20132947 (2009).","journal-title":"Int. J. Cancer"},{"key":"1165_CR97","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","volume":"10","author":"R Baan","year":"2009","unstructured":"Baan, R. et al. A review of human carcinogens-part F: chemical agents and related occupations. Lancet Oncol. 10, 1143\u20131144 (2009).","journal-title":"Lancet Oncol."},{"key":"1165_CR98","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/nu14051027","volume":"14","author":"T Chen","year":"2022","unstructured":"Chen, T., Liu, J., Li, Y. & Wei, S. Burden of disease associated with dietary exposure to aflatoxins in China in 2020. Nutrients 14, 1027 (2022).","journal-title":"Nutrients"},{"key":"1165_CR99","unstructured":"Ministry of Agriculture and Rural Affairs. The Food and Nutrition Development Guideline (2025-2030) https:\/\/www.moa.gov.cn\/govpublic\/KJJYS\/202503\/t20250317_6471803.htm (2025)."},{"key":"1165_CR100","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard, V. et al. A review of human carcinogens\u2014part B: biological agents. Lancet Oncol. 10, 321\u2013322 (2009).","journal-title":"Lancet Oncol."},{"key":"1165_CR101","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","volume":"30","author":"KF Pan","year":"2024","unstructured":"Pan, K. F. et al. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat. Med. 30, 3250\u20133260 (2024).","journal-title":"Nat. Med."},{"key":"1165_CR102","doi-asserted-by":"publisher","first-page":"4636","DOI":"10.3748\/wjg.v30.i43.4636","volume":"30","author":"L Xie","year":"2024","unstructured":"Xie, L. et al. Prevalence of Helicobacter pylori infection in China from 2014-2023: a systematic review and meta-analysis. World J. Gastroenterol. 30, 4636\u20134656 (2024).","journal-title":"World J. Gastroenterol."},{"key":"1165_CR103","first-page":"279","volume":"32","author":"J Zhang","year":"2024","unstructured":"Zhang, J. Interpretation of key points from the white paper on Helicobacter pylori infection prevention and control in China. Chin. J. Integr. Tradit. West. Med. Dig. 32, 279\u2013282 (2024).","journal-title":"Chin. J. Integr. Tradit. West. Med. Dig."},{"key":"1165_CR104","first-page":"101193","volume":"51","author":"Z Hui","year":"2024","unstructured":"Hui, Z. et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg. Health West. Pac. 51, 101193 (2024).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1165_CR105","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.46234\/ccdcw2021.270","volume":"3","author":"National Health Commission Of The People\u2019s Republic of China.","year":"2021","unstructured":"National Health Commission Of The People\u2019s Republic of China. Childhood immunization schedule for national immunization program vaccines - China (version 2021). China CDC Wkly. 3, 1101\u20131108 (2021).","journal-title":"China CDC Wkly."},{"key":"1165_CR106","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1016\/S2468-2667(25)00254-3","volume":"10","author":"J Li","year":"2025","unstructured":"Li, J. et al. Seroepidemiology of hepatitis C virus infection in people aged 1-69 years in China: a national, cross-sectional study. Lancet Public Health 10, e1036\u2013e1044 (2025).","journal-title":"Lancet Public Health"},{"key":"1165_CR107","first-page":"627","volume":"4","author":"J Li","year":"2022","unstructured":"Li, J., Pang, L. & Liu, Z. Interpretation of the national action plan for eliminating hepatitis C as a public health threat (2021-2030). China CDC Wkly. 4, 627\u2013630 (2022).","journal-title":"China CDC Wkly."},{"key":"1165_CR108","first-page":"253","volume":"32","author":"National Center for AIDS\/STD Control and Prevention of China CDC.","year":"2026","unstructured":"National Center for AIDS\/STD Control and Prevention of China CDC. National HIV\/STD epidemic update, December 2025. Chin. J. AIDS STD 32, 253 (2026).","journal-title":"Chin. J. AIDS STD"},{"key":"1165_CR109","first-page":"91","volume":"10","author":"General Office of the State Council of the People\u2019s Republic of China.","year":"2025","unstructured":"General Office of the State Council of the People\u2019s Republic of China. China\u2019s plan for HIV\/AIDS prevention and control (2024\u20132030). J. Emerg. Infect. Dis. 10, 91\u201393 (2025).","journal-title":"J. Emerg. Infect. Dis."},{"key":"1165_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03975-6","volume":"23","author":"S Han","year":"2025","unstructured":"Han, S. et al. Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases. BMC Med. 23, 158 (2025).","journal-title":"BMC Med."},{"key":"1165_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60999-5","volume":"16","author":"MF Ji","year":"2025","unstructured":"Ji, M. F. et al. Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat. Commun. 16, 5940 (2025).","journal-title":"Nat. Commun."},{"key":"1165_CR112","first-page":"329","volume":"47","author":"Z Wu","year":"2025","unstructured":"Wu, Z. et al. Research progress on nasopharyngeal carcinoma screening. Chin. J. Cell Biol. 47, 329\u2013335 (2025).","journal-title":"Chin. J. Cell Biol."},{"key":"1165_CR113","unstructured":"National Disease Control and Prevention Administration. National Comprehensive Prevention and Control Plan for Echinococcosis and Other Key Parasitic Diseases (2024\u20132030) https:\/\/www.ndcpa.gov.cn\/jbkzzx\/c100081\/common\/content\/content_1788432040413999104.html (2024)."},{"key":"1165_CR114","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.jinf.2025.106528","volume":"91","author":"MB Qian","year":"2025","unstructured":"Qian, M. B. et al. Clonorchiasis in China: geospatial modeling of the population infected and at risk, based on national surveillance. J. Infect. 91, 106528 (2025).","journal-title":"J. Infect."},{"key":"1165_CR115","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3201\/eid1801.102070","volume":"18","author":"T Zhang","year":"2012","unstructured":"Zhang, T. et al. Human herpesvirus 8 seroprevalence, China. Emerg. Infect. Dis. 18, 150\u2013152 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"1165_CR116","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1470-2045(09)70213-X","volume":"10","author":"F El Ghissassi","year":"2009","unstructured":"El Ghissassi, F. et al. A review of human carcinogens\u2014part D: radiation. Lancet Oncol. 10, 751\u2013752 (2009).","journal-title":"Lancet Oncol."},{"key":"1165_CR117","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S1470-2045(13)70487-X","volume":"14","author":"D Loomis","year":"2013","unstructured":"Loomis, D. et al. The carcinogenicity of outdoor air pollution. Lancet Oncol. 14, 1262\u20131263 (2013).","journal-title":"Lancet Oncol."},{"key":"1165_CR118","first-page":"1294","volume":"37","author":"X Miao","year":"2024","unstructured":"Miao, X. et al. Indoor radon survey in 31 provincial capital cities and estimation of lung cancer risk in urban areas of China. Biomed. Environ. Sci. 37, 1294\u20131302 (2024).","journal-title":"Biomed. Environ. Sci."},{"key":"1165_CR119","unstructured":"State Council of China. Carbon Peaking and Carbon Neutrality China\u2019s Plans and Solutions https:\/\/english.www.gov.cn\/archive\/whitepaper\/202511\/08\/content_WS690ee812c6d00ca5f9a076cd.html (2025)."},{"key":"1165_CR120","unstructured":"Standardization Administration of China. Requirements for control of indoor radon and its progeny. Vol. GB\/T 16146-2015, 1\u20136 (Standards Press of China, 2015)."},{"key":"1165_CR121","doi-asserted-by":"publisher","first-page":"112165","DOI":"10.1016\/j.enpol.2021.112165","volume":"151","author":"C Liu","year":"2021","unstructured":"Liu, C., Zhu, B., Ni, J. & Wei, C. Residential coal-switch policy in China: development, achievement, and challenge. Energy Policy 151, 112165 (2021).","journal-title":"Energy Policy"},{"key":"1165_CR122","unstructured":"National Disease Control and Prevention Administration. Implementation Plan for the Healthy Environment Promotion Initiative (2025-2030) https:\/\/www.ndcpa.gov.cn\/jbkzzx\/c100014\/common\/content\/content_1952335475719442432.html (2025)."},{"key":"1165_CR123","unstructured":"Ministry of Ecology and Environment. The National Ecological Meteorological Bulletin (2024) https:\/\/www.mee.gov.cn\/hjzl\/sthjzk\/zghjzkgb\/ (2025)."},{"key":"1165_CR124","doi-asserted-by":"publisher","first-page":"985","DOI":"10.12677\/OJNS.2021.96107","volume":"9","author":"Bai T","year":"2021","unstructured":"Bai, T. Study on the use of sunscreen products based on the spatial and temporal distribution characteristics of UV index in China. Open J. Nat. Sci. 9, 985\u20131002 (2021).","journal-title":"Open J. Nat. Sci."},{"key":"1165_CR125","doi-asserted-by":"publisher","first-page":"314","DOI":"10.46234\/ccdcw2020.080","volume":"2","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. History of the development of the reporting system of occupational diseases and occupational disease list in China. China CDC Wkly. 2, 314\u2013318 (2020).","journal-title":"China CDC Wkly."},{"key":"1165_CR126","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41568-022-00494-x","volume":"22","author":"S Das","year":"2022","unstructured":"Das, S. et al. Aristolochic acid-associated cancers: a public health risk in need of global action. Nat. Rev. Cancer 22, 576\u2013591 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1165_CR127","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S1470-2045(08)70173-6","volume":"9","author":"P Boffetta","year":"2008","unstructured":"Boffetta, P., Hecht, S., Gray, N., Gupta, P. & Straif, K. Smokeless tobacco and cancer. Lancet Oncol. 9, 667\u2013675 (2008).","journal-title":"Lancet Oncol."},{"key":"1165_CR128","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1470-2045(24)00458-3","volume":"25","author":"H Rumgay","year":"2024","unstructured":"Rumgay, H. et al. Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25, 1413\u20131423 (2024).","journal-title":"Lancet Oncol."},{"key":"1165_CR129","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/M17-2000","volume":"168","author":"C Yu","year":"2018","unstructured":"Yu, C. et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann. Intern. Med. 168, 489\u2013497 (2018).","journal-title":"Ann. Intern. Med."},{"key":"1165_CR130","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jamaoncol.2020.6575","volume":"7","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial. JAMA Oncol. 7, 263\u2013270 (2021).","journal-title":"JAMA Oncol."},{"key":"1165_CR131","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bjc.2015.33","volume":"112","author":"S Shen","year":"2015","unstructured":"Shen, S. et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br. J. Cancer 112, 998\u20131004 (2015).","journal-title":"Br. J. Cancer"},{"key":"1165_CR132","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395\u2013409 (2011).","journal-title":"N. Engl. J. Med."},{"key":"1165_CR133","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gutjnl-2019-320200","volume":"70","author":"R Chen","year":"2021","unstructured":"Chen, R. et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut 70, 251\u2013260 (2021).","journal-title":"Gut"},{"key":"1165_CR134","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1053\/j.gastro.2024.11.025","volume":"168","author":"C Xia","year":"2025","unstructured":"Xia, C. et al. Effect of an endoscopy screening on upper gastrointestinal cancer mortality: a community-based multicenter cluster randomized clinical trial. Gastroenterology 168, 725\u2013740 (2025).","journal-title":"Gastroenterology"},{"key":"1165_CR135","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s43018-023-00618-8","volume":"4","author":"H Zeng","year":"2023","unstructured":"Zeng, H. et al. Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study. Nat. Cancer 4, 1382\u20131394 (2023).","journal-title":"Nat. Cancer"},{"key":"1165_CR136","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","volume":"387","author":"M Bretthauer","year":"2022","unstructured":"Bretthauer, M. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N. Engl. J. Med. 387, 1547\u20131556 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1165_CR137","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa2301496","volume":"389","author":"T Li","year":"2023","unstructured":"Li, T. et al. Anti-Epstein-Barr virus BNLF2b for mass screening for nasopharyngeal cancer. N. Engl. J. Med. 389, 808\u2013819 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1165_CR138","first-page":"911","volume":"46","author":"National Health Commission.","year":"2024","unstructured":"National Health Commission. Lung cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 911\u2013912 (2024).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR139","first-page":"917","volume":"46","author":"National Health Commission.","year":"2024","unstructured":"National Health Commission. Colorectal cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 917\u2013918 (2024).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR140","first-page":"913","volume":"46","author":"National Health Commission.","year":"2024","unstructured":"National Health Commission. Esophageal cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 913\u2013914 (2024).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR141","first-page":"915","volume":"46","author":"National Health Commission.","year":"2024","unstructured":"National Health Commission. Gastric cancer screening protocol (2024 edition). Chin. J. Oncol. 46, 915\u2013916 (2024).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR142","first-page":"779","volume":"44","author":"J He","year":"2022","unstructured":"He, J. et al. China guideline for liver cancer screening (2022, Beijing). Chin. J. Oncol. 44, 779\u2013814 (2022).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR143","unstructured":"National Health Commission. Breast Cancer and Cervical Cancer Screening Protocol https:\/\/www.nhc.gov.cn\/fys\/c100078\/202201\/e4209b0a6e604f6aba3e793d8eddebf3.shtml(2022)."},{"key":"1165_CR144","first-page":"456","volume":"47","author":"C Lin","year":"2025","unstructured":"Lin, C. & Chen, W. Overview of screening and early detection of primary malignant tumors in general population in China. Chin. J. Oncol. 47, 456\u2013462 (2025).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217457","volume":"612","author":"N Tan","year":"2025","unstructured":"Tan, N. et al. Extending breast cancer screening beyond age 45-64 years in China: a cost-effectiveness analysis. Cancer Lett. 612, 217457 (2025).","journal-title":"Cancer Lett."},{"key":"1165_CR146","unstructured":"National Health Commission. Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030) https:\/\/www.nhc.gov.cn\/fys\/c100078\/202301\/001debf5e15f4da99d03aac3a803b2de.shtml (2023)."},{"key":"1165_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101594","volume":"52","author":"W Cao","year":"2022","unstructured":"Cao, W. et al. Uptake of lung cancer screening with low-dose computed tomography in China: a multi-centre population-based study. EClinicalMedicine 52, 101594 (2022).","journal-title":"EClinicalMedicine"},{"key":"1165_CR148","first-page":"23","volume":"35","author":"M Zhao","year":"2026","unstructured":"Zhao, M. et al. Analysis of compliance and influencing factors of lung cancer screening among residents in Yangzhong City, Jiangsu Province from 2024 to 2025. China Cancer 35, 23\u201331 (2026).","journal-title":"China Cancer"},{"key":"1165_CR149","doi-asserted-by":"publisher","first-page":"188","DOI":"10.24920\/004446","volume":"42","author":"X Zhang","year":"2025","unstructured":"Zhang, X., Fang, Y. & Pang, Y. Analysis of social screening results of lung cancer among rural residents in Shaanxi Province from 2020 to 2023. Chin. J. Soc. Med. 42, 188\u2013191 (2025).","journal-title":"Chin. J. Soc. Med."},{"key":"1165_CR150","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/gutjnl-2018-317124","volume":"68","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut 68, 1450\u20131457 (2019).","journal-title":"Gut"},{"key":"1165_CR151","first-page":"727","volume":"34","author":"P Zheng","year":"2022","unstructured":"Zheng, P., Lu, L., Zhu, F. & Dai, S. Analysis of colorectal cancer screening results in Yongjia County. J. Prev. Med. 34, 727\u2013731 (2022).","journal-title":"J. Prev. Med."},{"key":"1165_CR152","first-page":"603","volume":"32","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Analysis of screening results and compliance of colorectal cancer among rural residents in Beijing, 2017-2021. China Cancer 32, 603\u2013609 (2023).","journal-title":"China Cancer"},{"key":"1165_CR153","first-page":"4332","volume":"52","author":"J Ma","year":"2025","unstructured":"Ma, J. et al. Colorectal cancer screening results and colonoscopy compliance among rural residents in Sichuan Province. Mod. Prev. Med. 52, 4332\u20134338 (2025).","journal-title":"Mod. Prev. Med."},{"key":"1165_CR154","doi-asserted-by":"publisher","DOI":"10.2196\/45360","volume":"9","author":"H Li","year":"2023","unstructured":"Li, H. et al. Profiles and findings of population-based esophageal cancer screening with endoscopy in China: systematic review and meta-analysis. JMIR Public Health Surveill. 9, e45360 (2023).","journal-title":"JMIR Public Health Surveill."},{"key":"1165_CR155","first-page":"1","volume":"29","author":"W Chen","year":"2020","unstructured":"Chen, W., Li, N. & Cao, M. Preliminary analysis of cancer screening program in Urban China from 2013 to 2017. China Cancer 29, 1\u20136 (2020).","journal-title":"China Cancer"},{"key":"1165_CR156","first-page":"648","volume":"33","author":"C Xia","year":"2025","unstructured":"Xia, C. et al. Baseline results for the Cancer Screening Program in Huai River areas from 2007 to 2023. Chin. J. Prev. Control Chron. Dis. 33, 648\u2013654 (2025).","journal-title":"Chin. J. Prev. Control Chron. Dis."},{"key":"1165_CR157","first-page":"101","volume":"1","author":"J Li","year":"2021","unstructured":"Li, J. et al. Trends in high-risk rates and screening rates for the population-based cancer screening program on esophageal, stomach and liver cancer in China, 2010-2016. J. Natl Cancer Cent. 1, 101\u2013107 (2021).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR158","first-page":"497","volume":"43","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Breast ultrasound optimization process analysis based on breast cancer screening for 1,501,753 rural women in China. Chin. J. Oncol. 43, 497\u2013503 (2021).","journal-title":"Chin. J. Oncol."},{"key":"1165_CR159","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1200\/JCO.23.01296","volume":"43","author":"WJ Chen","year":"2025","unstructured":"Chen, W. J. et al. Impact of an Epstein-Barr virus serology-based screening program on nasopharyngeal carcinoma mortality: a cluster-randomized controlled trial. J. Clin. Oncol. 43, 22\u201331 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1165_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106927","volume":"155","author":"V Baccolini","year":"2022","unstructured":"Baccolini, V. et al. The association between adherence to cancer screening programs and health literacy: a systematic review and meta-analysis. Prev. Med. 155, 106927 (2022).","journal-title":"Prev. Med."},{"key":"1165_CR161","doi-asserted-by":"publisher","first-page":"100068","DOI":"10.1016\/j.apjon.2022.04.007","volume":"9","author":"Y Bai","year":"2022","unstructured":"Bai, Y., Wong, C. L., Peng, X., Choi, K. C. & So, W. K. W. Effectiveness of a tailored communication intervention on colonoscopy uptake for firstdegree relatives of colorectal cancer patients: a randomized controlled trial. Asia Pac. J. Oncol. Nurs. 9, 100068 (2022).","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"1165_CR162","unstructured":"World Health Organization. A Short Guide to Cancer Screening: Increase Effectiveness, Maximize Benefits and Minimize Harm (WHO, 2022)."},{"key":"1165_CR163","first-page":"633","volume":"19","author":"Z Dong","year":"2010","unstructured":"Dong, Z. et al. The exploration of evaluating indicators for early detection and treatment of cancers in China. China Cancer 19, 633\u2013638 (2010).","journal-title":"China Cancer"},{"key":"1165_CR164","doi-asserted-by":"publisher","first-page":"1491226","DOI":"10.3389\/fpubh.2025.1491226","volume":"13","author":"A Jabbari","year":"2025","unstructured":"Jabbari, A., Najafpour, Z., Ourang, S. & Cheraghi, M. Developing and validating key performance indicators for breast, cervical, and colorectal cancer screening programs: a literature review and Delphi survey. Front. Public Health 13, 1491226 (2025).","journal-title":"Front. Public Health"},{"key":"1165_CR165","unstructured":"National Health Commission. Reply to the \u201cSuggestions on Further Strengthening the Efforts of Cancer Prevention and Control in China\u201d https:\/\/www.nhc.gov.cn\/wjw\/jiany\/202409\/24aab6de664a4bb0805951f3ac50a493.shtml (2024)."},{"key":"1165_CR166","first-page":"88","volume":"4","author":"XY Zhi","year":"2012","unstructured":"Zhi, X. Y. et al. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011). J. Thorac. Dis. 4, 88\u2013101 (2012).","journal-title":"J. Thorac. Dis."},{"key":"1165_CR167","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1002\/cncr.29550","volume":"121","author":"XY Zhi","year":"2015","unstructured":"Zhi, X. Y., Yu, J. M. & Shi, Y. K. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer 121, 3165\u20133181 (2015).","journal-title":"Cancer"},{"key":"1165_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2019.01.01","volume":"31","author":"National health Commission.","year":"2019","unstructured":"National health Commission. Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version). Chin. J. Cancer Res. 31, 1\u201328 (2019).","journal-title":"Chin. J. Cancer Res."},{"key":"1165_CR169","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21147\/j.issn.1000-9604.2022.03.03","volume":"34","author":"Health Commission Of The People\u2019s Republic Of China.","year":"2022","unstructured":"Health Commission Of The People\u2019s Republic Of China. National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version). Chin. J. Cancer Res. 34, 176\u2013206 (2022).","journal-title":"Chin. J. Cancer Res."},{"key":"1165_CR170","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1038\/s41591-023-02655-3","volume":"29","author":"Z Lu","year":"2023","unstructured":"Lu, Z. et al. The landscape of cancer research and cancer care in China. Nat. Med. 29, 3022\u20133032 (2023).","journal-title":"Nat. Med."},{"key":"1165_CR171","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrd.2016.200","volume":"15","author":"L Shao","year":"2016","unstructured":"Shao, L. et al. Regulatory watch: innovative drug availability in China. Nat. Rev. Drug Discov. 15, 739\u2013740 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1165_CR172","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.cell.2024.02.040","volume":"187","author":"F Wang","year":"2024","unstructured":"Wang, F., Ruan, D. Y. & Xu, R. H. Challenges and opportunities in oncology drug development and clinical research in China. Cell 187, 1578\u20131583 (2024).","journal-title":"Cell"},{"key":"1165_CR173","first-page":"129","volume":"3","author":"H Huang","year":"2023","unstructured":"Huang, H. et al. Growing research and development of targeted anticancer drugs in China. J. Natl Cancer Cent. 3, 129\u2013134 (2023).","journal-title":"J. Natl Cancer Cent."},{"key":"1165_CR174","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25973","volume":"5","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Overall survival benefits of cancer drugs approved in China from 2005 to 2020. JAMA Netw. Open 5, e2225973 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1165_CR175","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna, T. P. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371, m4087 (2020).","journal-title":"BMJ"},{"key":"1165_CR176","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1470-2045(19)30595-9","volume":"21","author":"MM Koo","year":"2020","unstructured":"Koo, M. M. et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 21, 73\u201379 (2020).","journal-title":"Lancet Oncol."},{"key":"1165_CR177","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1055-9965.EPI-25-0120","volume":"34","author":"K Agbedinu","year":"2025","unstructured":"Agbedinu, K. et al. A Scoping review on barriers to cancer diagnosis and care in low- and middle-income countries. Cancer Epidemiol. Biomarkers Prev. 34, 1066\u20131073 (2025).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1165_CR178","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00439","volume":"10","author":"OA Bamodu","year":"2024","unstructured":"Bamodu, O. A. & Chung, C. C. Cancer care disparities: overcoming barriers to cancer control in low- and middle-income countries. JCO Glob. Oncol. 10, e2300439 (2024).","journal-title":"JCO Glob. Oncol."},{"key":"1165_CR179","doi-asserted-by":"publisher","first-page":"627","DOI":"10.21147\/j.issn.1000-9604.2021.05.09","volume":"33","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008-2017. Chin. J. Cancer Res. 33, 627\u2013636 (2021).","journal-title":"Chin. J. Cancer Res."},{"key":"1165_CR180","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-087190","volume":"14","author":"N Peng","year":"2024","unstructured":"Peng, N. et al. Systematic review of the impact of the National Medication Price Negotiated Policy on the accessibility of drugs in China, 2016-2024. BMJ Open 14, e087190 (2024).","journal-title":"BMJ Open"},{"key":"1165_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004332","volume":"21","author":"J Zhou","year":"2024","unstructured":"Zhou, J., Lan, T., Lu, H. & Pan, J. Price negotiation and pricing of anticancer drugs in China: an observational study. PLoS Med. 21, e1004332 (2024).","journal-title":"PLoS Med."},{"key":"1165_CR182","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.1105","volume":"6","author":"J Gruber","year":"2025","unstructured":"Gruber, J., Lin, M., Yang, H. & Yi, J. China\u2019s social health insurance in the era of rapid population aging. JAMA Health Forum 6, e251105 (2025).","journal-title":"JAMA Health Forum"},{"key":"1165_CR183","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077089","volume":"14","author":"W Li","year":"2024","unstructured":"Li, W. et al. Access to innovative anticancer medicines in China: a national survey on availability, price and affordability. BMJ Open 14, e077089 (2024).","journal-title":"BMJ Open"},{"key":"1165_CR184","doi-asserted-by":"publisher","first-page":"912","DOI":"10.21147\/j.issn.1000-9604.2025.06.04","volume":"37","author":"W Cao","year":"2025","unstructured":"Cao, W., Qin, K., Liu, B. & Chen, W. Cancer statistics in China: epidemiology, risk factors, and prevention. Chin. J. Cancer Res. 37, 912\u2013928 (2025).","journal-title":"Chin. J. Cancer Res."},{"key":"1165_CR185","doi-asserted-by":"publisher","DOI":"10.2196\/43541","volume":"9","author":"S He","year":"2023","unstructured":"He, S. et al. Geographic, demographic, and socioeconomic disparities and factors associated with cancer literacy in China: national cross-sectional study. JMIR Public Health Surveill. 9, e43541 (2023).","journal-title":"JMIR Public Health Surveill."},{"key":"1165_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2025.105934","volume":"248","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. Diagnostic routes and symptom-to-treatment delays in gastric cancer: findings from a cross-sectional study in southeastern China. Public Health 248, 105934 (2025).","journal-title":"Public Health"},{"key":"1165_CR187","volume":"60","author":"W Xing","year":"2025","unstructured":"Xing, W. et al. Understanding and mitigating cancer-related financial toxicity in China: challenges and recommendations. Lancet Reg. Health West. Pac. 60, 101601 (2025).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1165_CR188","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s44178-024-00124-6","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Current situation and capacity of cancer diagnosis and treatment in county hospitals in China: a multicenter cross-sectional survey. Holist. Integr. Oncol. 3, 51 (2024).","journal-title":"Holist. Integr. Oncol."},{"key":"1165_CR189","doi-asserted-by":"publisher","first-page":"208","DOI":"10.35772\/ghm.2023.01014","volume":"5","author":"J Song","year":"2023","unstructured":"Song, J. et al. Current status of and future perspectives on care for cancer survivors in China. Glob. Health Med. 5, 208\u2013215 (2023).","journal-title":"Glob. Health Med."},{"key":"1165_CR190","doi-asserted-by":"publisher","first-page":"e1051","DOI":"10.1016\/S2468-2667(22)00251-1","volume":"7","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Universal health coverage in China: a serial national cross-sectional study of surveys from 2003 to 2018. Lancet Public Health 7, e1051\u2013e1063 (2022).","journal-title":"Lancet Public Health"},{"key":"1165_CR191","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S1470-2045(25)00329-8","volume":"26","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysis. Lancet Oncol. 26, 1252\u20131260 (2025).","journal-title":"Lancet Oncol."},{"key":"1165_CR192","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S1470-2045(22)00483-1","volume":"23","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. Accelerating the integration of China into the global development of innovative anticancer drugs. Lancet Oncol. 23, e515\u2013e520 (2022).","journal-title":"Lancet Oncol."},{"key":"1165_CR193","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2471\/BLT.18.214908","volume":"96","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. People-centred integrated care in urban China. Bull. World Health Organ. 96, 843\u2013852 (2018).","journal-title":"Bull. World Health Organ."},{"key":"1165_CR194","volume":"50","author":"W Dong","year":"2024","unstructured":"Dong, W. et al. Effect of the national integrated demonstration area for the prevention and control of noncommunicable diseases programme on behavioural risk factors in China: a synthetic difference-in-differences study. Lancet Reg. Health West. Pac. 50, 101167 (2024).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"1165_CR195","first-page":"423","volume":"27","author":"T Xu","year":"2015","unstructured":"Xu, T. Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China. Chin. J. Cancer Res. 27, 423\u2013427 (2015).","journal-title":"Chin. J. Cancer Res."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01165-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01165-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01165-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:01:50Z","timestamp":1793361710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01165-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":195,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1038\/s41571-026-01165-8","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"21 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}